Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 18, 2025, AB Science S.A. (AB.PA) has a market cap of $0.11 billion USD. According to our data, AB Science S.A. is ranked No.7522 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 18, 2025 | $0.11 B |
63.27%
|
| Dec 31, 2024 | $64.92 M |
-75.19%
|
| Dec 29, 2023 | $0.26 B |
-49.86%
|
| Dec 30, 2022 | $0.52 B |
-40.92%
|
| Dec 31, 2021 | $0.88 B |
6,003.76%
|
| Dec 31, 2020 | $14.47 M |
-96.35%
|
| Dec 31, 2019 | $0.40 B |
55.13%
|
| Dec 31, 2018 | $0.26 B |
-58.42%
|
| Dec 29, 2017 | $0.61 B |
-39.04%
|
| Dec 30, 2016 | $1.01 B |
10.59%
|
| Dec 30, 2015 | $0.91 B |
7.47%
|
| Dec 31, 2014 | $0.85 B |
-16.35%
|
| Dec 31, 2013 | $1.01 B |
7,682.81%
|
| Dec 28, 2012 | $13.01 M |
-97.01%
|
| Dec 30, 2011 | $0.44 B |
-25.06%
|
| Dec 30, 2010 | $0.58 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Pfizer
PFE
|
$125.57 B |
0.001 M
|
USA
|
 Novartis
NVS
|
$219.89 B |
0.932 B
|
Switzerland
|
 Merck
MRK
|
$196.28 B |
0.008 M
|
USA
|
 Bristol-Myers Squibb
BMY
|
$100.17 B |
-0.004 M
|
USA
|
 Sanofi
SNY
|
$124.64 B |
0.327 B
|
France
|
 GlaxoSmithKline
GSK
|
$72.79 B |
-0.000 M
|
UK
|
 AstraZeneca
AZN
|
$210.29 B |
0.735 B
|
UK
|
 Eli Lilly
LLY
|
$754.27 B |
0.008 M
|
USA
|
 Johnson & Johnson
JNJ
|
$379.48 B |
-0.003 M
|
USA
|
 Amgen
AMGN
|
$149.09 B |
0.124 B
|
USA
|
 AbbVie
ABBV
|
$306.02 B |
0.008 M
|
USA
|
 Biogen
BIIB
|
$17.36 B |
-0.001 M
|
USA
|
 Regeneron Pharmaceuticals
REGN
|
$61.57 B |
1.023 B
|
USA
|
 Gilead Sciences
GILD
|
$130.32 B |
-0.001 M
|
USA
|
| Market Cap | = | AB.PA Stock Price | * | AB.PA Shares Outstanding |
| = | $1.64 | * | 64.59 M | |
| = | $0.11 B |